Bottom line
What does SWHFX hold?
SWHFX held 80 positions as of Jul 31, 2026. Its largest holding is Eli Lilly & Co at 13.92% of the fund, and the top 10 positions add up to 49.9%. By asset type it is 99% stocks.
Updated Sep 24, 2026
SWHFX top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | Stocks | 13.92% | $89.4M |
| 2 | Johnson & Johnson | Stocks | 6.94% | $44.6M |
| 3 | AbbVie Inc | Stocks | 5.81% | $37.3M |
| 4 | Merck & Co Inc | Stocks | 4.98% | $32.0M |
| 5 | UnitedHealth Group Inc | Stocks | 4.74% | $30.4M |
| 6 | Gilead Sciences Inc | Stocks | 3.24% | $20.8M |
| 7 | Novartis AG | Stocks | 2.92% | $18.8M |
| 8 | Amgen Inc | Stocks | 2.58% | $16.6M |
| 9 | Bristol-Myers Squibb Co | Stocks | 2.44% | $15.7M |
| 10 | Medtronic PLC | Stocks | 2.29% | $14.7M |
| 11 | Roche Holding AG | Stocks | 2.29% | $14.7M |
| 12 | Thermo Fisher Scientific Inc | Stocks | 2.16% | $13.8M |
| 13 | Stryker Corp | Stocks | 2.11% | $13.5M |
| 14 | Vertex Pharmaceuticals Inc | Stocks | 1.89% | $12.1M |
| 15 | Gsk Plc | Stocks | 1.73% | $11.1M |
| 16 | Boston Scientific Corp | Stocks | 1.60% | $10.3M |
| 17 | Abbott Laboratories | Stocks | 1.60% | $10.3M |
| 18 | Cigna Group/The | Stocks | 1.51% | $9.7M |
| 19 | Danaher Corp | Stocks | 1.47% | $9.4M |
| 20 | Elevance Health Inc | Stocks | 1.45% | $9.3M |
| 21 | Incyte Corp | Stocks | 1.37% | $8.8M |
| 22 | Ipsen SA | Stocks | 1.34% | $8.6M |
| 23 | Sanofi SA | Stocks | 1.31% | $8.4M |
| 24 | Becton Dickinson & Co | Stocks | 1.24% | $8.0M |
| 25 | Astellas Pharma Inc | Stocks | 1.19% | $7.6M |
Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 24, 2026